Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Zand Street, Shiraz, Iran.
Int Ophthalmol. 2023 Sep;43(9):3157-3164. doi: 10.1007/s10792-023-02715-0. Epub 2023 May 17.
To evaluate the efficacy of Repeated CXL (Re-CXL) and determine probable risk factors that lead to Re-CXL in patients with progressive keratoconus.
In this retrospective study, the medical records of patients who had been re-operated in our center between 2014 to 2020 due to progressive keratoconus were evaluated; seven eyes of seven patients had undergone Re-CXL procedure. Pre- and post-treatment variables were recorded and analyzed using IBM SPSS Statistics software.
The mean interval between the 1st and 2nd CXL was 49.71 months (range 12-72 months). Out of 7 patients for whom Re-CXL was considered necessary, eye rubbing was detected in 6 patients. Six patients were very young with a mean age of 13 years at primary CXL and 16.83 years at Re-CXL. Visual acuity and astigmatism did not change significantly after the Re-CXL procedure (p-values = 0.18, 0.91, respectively). When measurements of these indices prior to Re-CXL and post Re-CXL were compared, K1 (p-value = 0.01), K2 (p-value = 0.01), Kmean (p-value = 0.01), and Kmax (p-value = 0.008) changed significantly. As to pachymetry (p-value = 0.46), it did not change significantly. Kmax value regressed in all eyes after Re-CXL.
Re-CXL procedure was effective in halting the progression of disease. As to the risk factors, eye rubbed-related mechanism like eye rubbing and VKC, lower age, and pre-operative Kmax value > 58 D are the risk factors of Re-CXL procedure.
评估重复交联(Re-CXL)的疗效,并确定导致圆锥角膜进展的患者需要 Re-CXL 的可能危险因素。
在这项回顾性研究中,评估了 2014 年至 2020 年间因圆锥角膜在我院再次手术的患者的病历;7 名患者的 7 只眼接受了 Re-CXL 手术。使用 IBM SPSS Statistics 软件记录和分析治疗前后的变量。
第 1 次和第 2 次 CXL 之间的平均间隔为 49.71 个月(范围 12-72 个月)。在需要进行 Re-CXL 的 7 名患者中,有 6 名患者存在眼摩擦。6 名患者非常年轻,初次 CXL 时的平均年龄为 13 岁,Re-CXL 时的平均年龄为 16.83 岁。Re-CXL 后视力和散光没有明显变化(p 值分别为 0.18、0.91)。当比较 Re-CXL 前后这些指标的测量值时,K1(p 值=0.01)、K2(p 值=0.01)、Kmean(p 值=0.01)和 Kmax(p 值=0.008)均有显著变化。然而,角膜厚度(p 值=0.46)没有显著变化。所有眼的 Kmax 值在 Re-CXL 后均有下降。
Re-CXL 程序可有效阻止疾病进展。危险因素包括与眼摩擦相关的机制,如眼摩擦和 VKC、较低的年龄以及术前 Kmax 值>58 D。